Sales exec indicted in DOJ’s generic pharma probe
A federal grand jury has indicted a former Taro Pharmaceuticals executive on charges of participating in two conspiracies to fix prices, rig bids and allocate customers for generic pharmaceuticals.
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10